Blockade of iNOS by genetic deletion or by a specific inhibitor induced antifibrotic effects in a murine model of NASH that were accompanied by a decrease in MMP-9, suggesting an association among iNOS, MMP-9, and hepatic fibrosis [39]. The gene discussed is MMP9; the disease is Hepatic fibrosis.